Sunovion's Dasotraline To Be Filed In US For ADHD Despite Uncertainties

Sunovion is pressing ahead with plans for an FDA filing for its ADHD drug dasotraline in adult and children patients despite ongoing uncertainty over the drug's efficacy in the older grouping.